Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1196156-42-9

Post Buying Request

1196156-42-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1196156-42-9 Usage

General Description

Methyl 1H-pyrazolo[3,4-b]pyridine-5-carboxylate is a chemical compound with the molecular formula C9H7N3O2. It belongs to the pyrazolo[3,4-b]pyridine-5-carboxylate family and is commonly used in organic synthesis and pharmaceutical research. Methyl 1H-pyrazolo[3,4-b]pyridine-5-carboxylate is known for its potential therapeutic properties and is being studied for its potential applications in drug discovery. It is commonly used as a building block in the synthesis of various pharmaceutical compounds, and its unique structure and properties make it a valuable tool for medicinal chemistry research. Additionally, it is important to handle this chemical compound with caution and adhere to proper safety protocols due to its potential health hazards.

Check Digit Verification of cas no

The CAS Registry Mumber 1196156-42-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,6,1,5 and 6 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1196156-42:
(9*1)+(8*1)+(7*9)+(6*6)+(5*1)+(4*5)+(3*6)+(2*4)+(1*2)=169
169 % 10 = 9
So 1196156-42-9 is a valid CAS Registry Number.

1196156-42-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name Methyl 1H-pyrazolo[3,4-b]pyridine-5-carboxylate

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1196156-42-9 SDS

1196156-42-9Relevant articles and documents

Zinc Acetate-Promoted Buchwald-Hartwig Couplings of Heteroaromatic Amines

Ayothiraman, Rajaram,Rangaswamy, Sundaramurthy,Maity, Prantik,Simmons, Eric M.,Beutner, Gregory L.,Janey, Jacob,Treitler, Daniel S.,Eastgate, Martin D.,Vaidyanathan, Rajappa

supporting information, p. 7420 - 7427 (2017/07/26)

Zinc salts have been shown to promote the Buchwald-Hartwig coupling of azaindoles and azaindazoles with heteroaryl chlorides to provide the corresponding 1-aryl-1H-azaindoles and 1-aryl-1H-azaindazoles. The substrate scope and mechanistic aspects of this reaction were explored.

Reversible Inhibitors Arrest ClpP in a Defined Conformational State that Can Be Revoked by ClpX Association

Pahl, Axel,Lakemeyer, Markus,Vielberg, Marie-Theres,Hackl, Mathias W.,Vomacka, Jan,Korotkov, Vadim S.,Stein, Martin L.,Fetzer, Christian,Lorenz-Baath, Katrin,Richter, Klaus,Waldmann, Herbert,Groll, Michael,Sieber, Stephan A.

supporting information, p. 15892 - 15896 (2016/01/29)

Caseinolytic protease P (ClpP) is an important regulator of Staphylococcus aureus pathogenesis. A high-throughput screening for inhibitors of ClpP peptidase activity led to the identification of the first non-covalent binder for this enzyme class. Co-crystallization of the small molecule with S. aureus ClpP revealed a novel binding mode: Because of the rotation of the conserved residue proline 125, ClpP is locked in a defined conformational state, which results in distortion of the catalytic triad and inhibition of the peptidase activity. Based on these structural insights, the molecule was optimized by rational design and virtual screening, resulting in derivatives exceeding the potency of previous ClpP inhibitors. Strikingly, the conformational lock is overturned by binding of ClpX, an associated chaperone that enables proteolysis by substrate unfolding in the ClpXP complex. Thus, regulation of inhibitor binding by associated chaperones is an unexpected mechanism important for ClpP drug development.

GPR40 RECEPTOR AGONIST, METHODS OF PREPARING THE SAME, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AS AN ACTIVE INGREDIENT

-

Paragraph 1389-1393;1501-1503, (2014/05/24)

The present invention relates to a novel compound having GPR40 receptor agonist activity that promotes insulin secretion and inhibits blood sugar rise after glucose loading, and is thereby useful for the treatment of diabetes and complications thereof, the preparation method thereof and pharmaceutical composition containing them as an active ingredient.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1196156-42-9